Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 18 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 11 |
NetGPI | no | yes: 0, no: 11 |
Term | Name | Level | Count |
---|---|---|---|
GO:0016020 | membrane | 2 | 9 |
GO:0110165 | cellular anatomical entity | 1 | 9 |
GO:0012505 | endomembrane system | 2 | 1 |
GO:0031201 | SNARE complex | 3 | 1 |
GO:0032991 | protein-containing complex | 1 | 1 |
GO:0098796 | membrane protein complex | 2 | 1 |
Related structures:
AlphaFold database: A4HES4
Term | Name | Level | Count |
---|---|---|---|
GO:0006810 | transport | 3 | 9 |
GO:0016192 | vesicle-mediated transport | 4 | 8 |
GO:0051179 | localization | 1 | 9 |
GO:0051234 | establishment of localization | 2 | 9 |
GO:0006886 | intracellular protein transport | 4 | 1 |
GO:0006906 | vesicle fusion | 6 | 1 |
GO:0006996 | organelle organization | 4 | 1 |
GO:0008104 | protein localization | 4 | 3 |
GO:0009987 | cellular process | 1 | 3 |
GO:0015031 | protein transport | 4 | 3 |
GO:0016043 | cellular component organization | 3 | 1 |
GO:0016050 | vesicle organization | 5 | 1 |
GO:0022406 | membrane docking | 2 | 1 |
GO:0033036 | macromolecule localization | 2 | 3 |
GO:0045184 | establishment of protein localization | 3 | 3 |
GO:0046907 | intracellular transport | 3 | 1 |
GO:0048278 | vesicle docking | 4 | 1 |
GO:0048284 | organelle fusion | 5 | 1 |
GO:0051640 | organelle localization | 2 | 1 |
GO:0051641 | cellular localization | 2 | 3 |
GO:0051649 | establishment of localization in cell | 3 | 1 |
GO:0061024 | membrane organization | 4 | 1 |
GO:0061025 | membrane fusion | 5 | 1 |
GO:0070727 | cellular macromolecule localization | 3 | 3 |
GO:0071702 | organic substance transport | 4 | 3 |
GO:0071705 | nitrogen compound transport | 4 | 3 |
GO:0071840 | cellular component organization or biogenesis | 2 | 1 |
GO:0090174 | organelle membrane fusion | 6 | 1 |
GO:0140056 | organelle localization by membrane tethering | 3 | 1 |
Term | Name | Level | Count |
---|---|---|---|
GO:0000149 | SNARE binding | 3 | 1 |
GO:0005484 | SNAP receptor activity | 3 | 1 |
GO:0005488 | binding | 1 | 1 |
GO:0005515 | protein binding | 2 | 1 |
GO:0030674 | protein-macromolecule adaptor activity | 2 | 1 |
GO:0060090 | molecular adaptor activity | 1 | 1 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 67 | 71 | PF00656 | 0.602 |
CLV_NRD_NRD_1 | 128 | 130 | PF00675 | 0.353 |
CLV_PCSK_KEX2_1 | 130 | 132 | PF00082 | 0.357 |
CLV_PCSK_PC1ET2_1 | 130 | 132 | PF00082 | 0.412 |
CLV_PCSK_SKI1_1 | 202 | 206 | PF00082 | 0.308 |
CLV_PCSK_SKI1_1 | 80 | 84 | PF00082 | 0.380 |
DOC_MAPK_gen_1 | 178 | 186 | PF00069 | 0.608 |
DOC_MAPK_gen_1 | 228 | 236 | PF00069 | 0.450 |
DOC_MAPK_MEF2A_6 | 228 | 236 | PF00069 | 0.448 |
DOC_USP7_UBL2_3 | 216 | 220 | PF12436 | 0.379 |
LIG_14-3-3_CanoR_1 | 171 | 179 | PF00244 | 0.703 |
LIG_14-3-3_CanoR_1 | 50 | 60 | PF00244 | 0.488 |
LIG_Actin_RPEL_3 | 221 | 240 | PF02755 | 0.519 |
LIG_AP2alpha_2 | 28 | 30 | PF02296 | 0.578 |
LIG_BIR_II_1 | 1 | 5 | PF00653 | 0.548 |
LIG_EH1_1 | 237 | 245 | PF00400 | 0.395 |
LIG_FHA_1 | 146 | 152 | PF00498 | 0.678 |
LIG_FHA_1 | 243 | 249 | PF00498 | 0.218 |
LIG_FHA_2 | 23 | 29 | PF00498 | 0.694 |
LIG_FHA_2 | 83 | 89 | PF00498 | 0.552 |
LIG_FHA_2 | 94 | 100 | PF00498 | 0.540 |
LIG_LIR_Nem_3 | 245 | 249 | PF02991 | 0.201 |
LIG_LIR_Nem_3 | 27 | 33 | PF02991 | 0.566 |
LIG_SUMO_SIM_par_1 | 239 | 245 | PF11976 | 0.173 |
LIG_TRAF2_1 | 96 | 99 | PF00917 | 0.564 |
LIG_WRC_WIRS_1 | 243 | 248 | PF05994 | 0.201 |
MOD_CK1_1 | 2 | 8 | PF00069 | 0.543 |
MOD_CK1_1 | 55 | 61 | PF00069 | 0.682 |
MOD_CK1_1 | 68 | 74 | PF00069 | 0.584 |
MOD_CK2_1 | 68 | 74 | PF00069 | 0.596 |
MOD_CK2_1 | 82 | 88 | PF00069 | 0.568 |
MOD_CK2_1 | 93 | 99 | PF00069 | 0.598 |
MOD_GlcNHglycan | 173 | 176 | PF01048 | 0.484 |
MOD_GSK3_1 | 141 | 148 | PF00069 | 0.539 |
MOD_GSK3_1 | 2 | 9 | PF00069 | 0.564 |
MOD_GSK3_1 | 51 | 58 | PF00069 | 0.592 |
MOD_GSK3_1 | 89 | 96 | PF00069 | 0.672 |
MOD_N-GLC_1 | 141 | 146 | PF02516 | 0.435 |
MOD_N-GLC_1 | 52 | 57 | PF02516 | 0.294 |
MOD_NEK2_1 | 221 | 226 | PF00069 | 0.475 |
MOD_NEK2_1 | 51 | 56 | PF00069 | 0.627 |
MOD_PIKK_1 | 189 | 195 | PF00454 | 0.630 |
MOD_PKA_1 | 216 | 222 | PF00069 | 0.502 |
MOD_PKA_2 | 170 | 176 | PF00069 | 0.682 |
MOD_PKA_2 | 179 | 185 | PF00069 | 0.608 |
MOD_Plk_1 | 165 | 171 | PF00069 | 0.618 |
MOD_Plk_1 | 52 | 58 | PF00069 | 0.493 |
MOD_Plk_2-3 | 165 | 171 | PF00069 | 0.618 |
MOD_Plk_4 | 242 | 248 | PF00069 | 0.205 |
MOD_Plk_4 | 55 | 61 | PF00069 | 0.555 |
MOD_SUMO_rev_2 | 188 | 192 | PF00179 | 0.509 |
TRG_DiLeu_BaEn_2 | 145 | 151 | PF01217 | 0.606 |
TRG_ER_diArg_1 | 129 | 132 | PF00400 | 0.607 |
TRG_NES_CRM1_1 | 198 | 212 | PF08389 | 0.519 |
TRG_Pf-PMV_PEXEL_1 | 159 | 163 | PF00026 | 0.324 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N0P4C8 | Leptomonas seymouri | 27% | 100% |
A0A0N1IK90 | Leptomonas seymouri | 76% | 97% |
A0A0S4JJL1 | Bodo saltans | 40% | 100% |
A0A1X0NSP4 | Trypanosomatidae | 57% | 100% |
A0A3Q8IDN9 | Leishmania donovani | 84% | 100% |
A0A3R7KG01 | Trypanosoma rangeli | 57% | 100% |
A0A3R7M3G3 | Trypanosoma rangeli | 30% | 100% |
A4HBK1 | Leishmania braziliensis | 37% | 100% |
A4I201 | Leishmania infantum | 84% | 100% |
E9AY48 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 83% | 100% |
O43752 | Homo sapiens | 29% | 98% |
O60499 | Homo sapiens | 25% | 100% |
Q4Q9C5 | Leishmania major | 82% | 100% |
Q5R6Q2 | Pongo abelii | 29% | 98% |
Q63635 | Rattus norvegicus | 30% | 98% |
Q946Y7 | Arabidopsis thaliana | 27% | 100% |
Q9JKK1 | Mus musculus | 31% | 98% |
V5BUP0 | Trypanosoma cruzi | 56% | 100% |